Vanda Pharmaceuticals (VNDA) Leases (2019 - 2025)
Historic Leases for Vanda Pharmaceuticals (VNDA) over the last 7 years, with Q3 2025 value amounting to $5.1 million.
- Vanda Pharmaceuticals' Leases fell 1570.81% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year decrease of 1570.81%. This contributed to the annual value of $5.6 million for FY2024, which is 2113.19% down from last year.
- According to the latest figures from Q3 2025, Vanda Pharmaceuticals' Leases is $5.1 million, which was down 1570.81% from $5.2 million recorded in Q2 2025.
- Vanda Pharmaceuticals' 5-year Leases high stood at $10.2 million for Q1 2021, and its period low was $5.1 million during Q3 2025.
- Moreover, its 5-year median value for Leases was $7.8 million (2023), whereas its average is $7.6 million.
- In the last 5 years, Vanda Pharmaceuticals' Leases plummeted by 626.21% in 2021 and then tumbled by 2275.29% in 2025.
- Vanda Pharmaceuticals' Leases (Quarter) stood at $9.3 million in 2021, then fell by 9.4% to $8.4 million in 2022, then dropped by 15.44% to $7.1 million in 2023, then dropped by 21.13% to $5.6 million in 2024, then fell by 9.48% to $5.1 million in 2025.
- Its last three reported values are $5.1 million in Q3 2025, $5.2 million for Q2 2025, and $5.2 million during Q1 2025.